Jean Marc Bellemin is Chief Financial Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 56,204 shares of IOVA, which is worth approximately $209,640. The most recent transaction as insider was on Mar 03, 2025, when has been sold 31,734 shares (Common Stock) at a price of $4.04 per share, resulting in proceeds of $128,205. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 56.2K
91.51% 3M change
215.74% 12M change
Total Value Held $209,640

Jean-Marc Bellemin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2025
SELL
Payment of exercise price or tax liability
$128,205 $4.04 p/Share
31,734 Reduced 36.09%
56,204 Common Stock
Mar 03 2025
BUY
Exercise of conversion of derivative security
-
58,590 Added 39.99%
87,938 Common Stock
Sep 03 2024
SELL
Payment of exercise price or tax liability
$129,017 $10.85 p/Share
11,891 Reduced 28.83%
29,348 Common Stock
Sep 03 2024
BUY
Exercise of conversion of derivative security
-
23,438 Added 36.24%
41,239 Common Stock
Jan 03 2023
SELL
Payment of exercise price or tax liability
$64,478 $6.11 p/Share
10,553 Reduced 37.22%
17,801 Common Stock
Jan 03 2023
BUY
Exercise of conversion of derivative security
-
18,850 Added 39.93%
28,354 Common Stock
Jun 14 2022
SELL
Payment of exercise price or tax liability
$72,245 $7.73 p/Share
9,346 Reduced 49.58%
9,504 Common Stock
Jun 14 2022
BUY
Exercise of conversion of derivative security
-
18,850 Added 50.0%
18,850 Common Stock
JB

Jean Marc Bellemin

Chief Financial Officer
San Carlos, CA

Track Institutional and Insider Activities on IOVA

Follow IOVANCE BIOTHERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA